Christian Termeer

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Journal: Allergologie select

Published: May 06, 2026

The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany.

The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 13, 2023

Modelling of patient journey in chronic spontaneous urticaria: Increasing awareness and education by shorten patients' disease journey in Germany.

Modelling of patient journey in chronic spontaneous urticaria: Increasing awareness and education by shorten patients' disease journey in Germany.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 04, 2023

Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naïve patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled phase IIIb trial (POLARIS).

Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naïve patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled phase IIIb trial (POLARIS).

Journal: The British journal of dermatology

Published: August 03, 2023

Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS).

Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS).

Journal: The British journal of dermatology

Published: November 07, 2019

Long-term use of fumaric acid esters for the treatment of psoriasis in daily practice.

Long-term use of fumaric acid esters for the treatment of psoriasis in daily practice.

Journal: The Journal of dermatological treatment

Published: November 05, 2019

Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.

Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 04, 2017

Chronic spontaneous urticaria - a management pathway for patients with chronic spontaneous urticaria.

Chronic spontaneous urticaria - a management pathway for patients with chronic spontaneous urticaria.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: April 29, 2015

Showing 1-8 of 8

Last Updated: 09/26/2026